Cargando…
New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury
Mucositis is a common complication of chemotherapy, radiotherapy and targeted agents. It often affects compliance to anticancer therapies as it frequently causes schedule delays, interruptions or discontinuations of treatment. Moreover, the economic impact related to the management of mucositis is t...
Autores principales: | Cinausero, Marika, Aprile, Giuseppe, Ermacora, Paola, Basile, Debora, Vitale, Maria G., Fanotto, Valentina, Parisi, Giuseppe, Calvetti, Lorenzo, Sonis, Stephen T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462992/ https://www.ncbi.nlm.nih.gov/pubmed/28642709 http://dx.doi.org/10.3389/fphar.2017.00354 |
Ejemplares similares
-
Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities
por: Mancini, Maria L., et al.
Publicado: (2014) -
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside
por: Basile, Debora, et al.
Publicado: (2019) -
Molecular classifications of gastric cancers: Novel insights and possible future applications
por: Garattini, Silvio Ken, et al.
Publicado: (2017) -
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker
por: Pelizzari, Giacomo, et al.
Publicado: (2019) -
Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
por: Han, Yaqin, et al.
Publicado: (2013)